A study published in the New England Journal of Medicine has found that patients given ketamine for the treatment of non-psychotic, treatment-resistant depression reported ‘non-inferior’ outcomes compared to electroconvulsive therapy. Electroconvulsive therapy (ECT) is a treatment that involves passing an electric current through a patient’s brain, [...]
Khiron Life Sciences, the leader in cannabinoid-based medicine in Latin America, is now bringing its flagship medicinal product, the full-spectrum cannabis extract KHIRIOX 12/14, to the UK. This THC-based medical formulation has gained significant popularity and is the most prescribed cannabis extract in Latin America. With [...]
Astrasana and Clever Leaves have partnered to establish an international supply agreement for medical cannabis extracts in Czech Republic and Switzerland. Clever Leaves Holdings Inc, a global medicinal cannabis company, announced today the arrival of their first shipment of medical cannabis extracts from Colombia to Switzerland-based [...]
Inexpensive in vitro Methods to Evaluate the Impact of Cannabinoid-containing Products on Sentinel Lactobacillus spp. S. Lewin 1, A. Hilyard2, H. Piscatelli1, A. Hangman1, D. Petrik1, P. Miles2, and C. Orser2 1MatMaCorp Inc, Lincoln NE; 2Apothercare LLC, Boston MA Abstract The public has readily embraced cannabidiol (CBD) [...]
Copyright © 2024 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
